Biotech / Pharma
Centinel Spine
Biotech / Pharma
Centinel Spine, a medtech company focused on spinal disc replacements and backed by Athyrium Capital Management, filed for an IPO. The filing is not yet priced, so no offering has completed.
Founded
Region
Investors
People